Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA

Journal of Neurology

Volumn 252, Issue 3, 2005, Pages 332-337

  Bos, Michiel J ^a   Van Goor, Mary Lou P J ^a   Koudstaal, Peter J ^a   Dippel, Diederik W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brain infarction; Homocysteine; Ischaemic attack; Transient

Indexed keywords

ANTITHROMBOCYTIC AGENT; COUMARIN DERIVATIVE; CYANOCOBALAMIN; FOLIC ACID; HEPARINOID; HOMOCYSTEINE; ORAL CONTRACEPTIVE AGENT; PYRIDOXINE;

ADULT; ARTERY DISEASE; ARTICLE; BLOOD LEVEL; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; FEMALE; GENERAL PRACTITIONER; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG EMBOLISM; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADOLESCENT; ADULT; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTINE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 17644399790     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0647-9     Document Type: Article

References (14)

1. Adams HPJ, Kappelle LJ, Biller J, Gordon DL, Love BB, Gomez F, et al. (1995) Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol 52:491-495
2. Berg BO (1989) Neurologic and diagnostic evaluation. In: Edwards MSB, Hoffman HJ (eds) Cerebro Vascular Disease in Children and Adolescents. Baltimore,Md: Williams and Wilkins, pp 47-67
3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057
4. Bots ML, Launer LJ, Lindemans J, Hoes AW, Hofman A, Witteman JC, et al. (1999) Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 159:38-44
5. Caplan ER, Estol C (1993) Stroke in children, adolescents, and young adults. In: Adams HPJ (ed) Handbook of cerebrovascular disease. New York, NY: Marcel Dekker Inc, pp 233-254
6. Del Ser T, Barba R, Herranz AS, Seijas V, Lopez-Manglano C, Domingo J, et al. (2001) Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients. Cerebrovasc Dis 12(2):91-98
7. Hart RG, Miller VT (1983) Cerebral infarction in young adults: a practical approach. Stroke 14:110-114
8. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395-1398
9. Tan NC, Venketasubramanian N, Tjia HT (2002) Hyperhomocyst(e)inemia and Risk of Ischemic Stroke Among Young Asian Adults. Stroke 33:1956
10. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, et al. (2004) Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death: The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. JAMA 291(5): 565-575
11. Vermeer SE, Dijk EJ v, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, et al. (2002) Homocysteine, Silent Brain Infarcts, and White Matter Lesions: The Rotterdam Scan Study. Ann Neurol 51:285-289
12. 6 on progression of sub clinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 355(9203):517-522
13. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050
14. rd (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 24(1):35-41